These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25070137)

  • 1. The importance of knowing testosterone levels in patients with prostate cancer.
    Kirby M
    BJU Int; 2014 Aug; 114(2):164-5. PubMed ID: 25070137
    [No Abstract]   [Full Text] [Related]  

  • 2. Low free testosterone levels predict disease reclassification in men with prostate cancer undergoing active surveillance.
    San Francisco IF; Rojas PA; DeWolf WC; Morgentaler A
    BJU Int; 2014 Aug; 114(2):229-35. PubMed ID: 24898919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between serum sex hormone levels and prostate cancer: effect of prostate cancer on serum testosterone levels.
    Imamoto T; Suzuki H; Utsumi T; Endo T; Takano M; Yano M; Kawamura K; Kamiya N; Nihei N; Naya Y; Ichikawa T
    Future Oncol; 2009 Sep; 5(7):1005-13. PubMed ID: 19792969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result.
    Fiamegos A; Varkarakis J; Kontraros M; Karagiannis A; Chrisofos M; Barbalias D; Deliveliotis C
    Int Braz J Urol; 2016; 42(5):925-931. PubMed ID: 27532110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low testosterone level predicts prostate cancer in re-biopsy in patients with high grade prostatic intraepithelial neoplasia.
    García-Cruz E; Piqueras M; Ribal MJ; Huguet J; Serapiao R; Peri L; Izquierdo L; Alcaraz A
    BJU Int; 2012 Sep; 110(6 Pt B):E199-202. PubMed ID: 22257176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prostate size on pathological outcome and biochemical recurrence after radical prostatectomy for prostate cancer: is it correlated with serum testosterone level?
    Verit A
    BJU Int; 2010 Nov; 106(10):1555. PubMed ID: 20977595
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment.
    Prasad SM; Keane TE; Bennett CL
    Urology; 2012 Jul; 80(1):168. PubMed ID: 22608794
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormonal predictors of prostate cancer.
    Sofikerim M; Eskicorapci S; Oruç O; Ozen H
    Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between prostate cancer and serum testosterone levels.
    Zhang PL; Rosen S; Veeramachaneni R; Kao J; DeWolf WC; Bubley G
    Prostate; 2002 Nov; 53(3):179-82. PubMed ID: 12386917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum inhibin--not a cause of low testosterone levels in hypogonadal prostate cancer?
    Lackner JE; Maerk I; Koller A; Bieglmayer C; Marberger M; Kratzik C; Schatzl G
    Urology; 2008 Nov; 72(5):1121-4. PubMed ID: 18407338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone measurement in patients with prostate cancer.
    Schulman CC; Irani J; Morote J; Schalken JA; Montorsi F; Chlosta PL; Heidenreich A
    Eur Urol; 2010 Jul; 58(1):65-74. PubMed ID: 20434831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment testosterone and metastatic relapse after prostate irradiation.
    Daniell HW
    Urology; 1999 Jan; 53(1):241. PubMed ID: 9886624
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Low age adjusted free testosterone levels correlate with poorly differentiated prostate cancer. I. F. San Francisco, M. M. Regan, W. C. DeWolf and A. F. Olumi, J Urol, 175: 1341-1346, 2006.
    Morales A
    J Urol; 2006 Dec; 176(6 Pt 1):2746; author reply 2746. PubMed ID: 17085212
    [No Abstract]   [Full Text] [Related]  

  • 14. Do testosterone levels have prognostic significance in patients with metastatic prostate cancer treated with combined androgen blockade?
    Yasuda Y; Fujii Y; Yuasa T; Yamamoto S; Yonese J; Fukui I
    Int J Urol; 2015 Jan; 22(1):132-3. PubMed ID: 25243521
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy.
    Tiguert R; Inman BA
    J Urol; 2003 Dec; 170(6 Pt 1):2392; author reply 2392. PubMed ID: 14634433
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relationship between serum testosterone levels and prostatic cancer].
    Rivera P; Tagle R; Mir S; González R
    Actas Urol Esp; 2003; 27(10):788-92. PubMed ID: 14735860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging.
    Morgentaler A; Rhoden EL; Guay A; Traish A
    BJU Int; 2010 Mar; 105(6):884-5; author reply 885-6. PubMed ID: 20353537
    [No Abstract]   [Full Text] [Related]  

  • 18. Potentially harmful effect of a testosterone dietary supplement on prostate cancer growth and metastasis.
    Shariat SF; Lamb DJ; Roehrborn CG; Slawin KM
    Arch Intern Med; 2008 Jan; 168(2):235-6. PubMed ID: 18227373
    [No Abstract]   [Full Text] [Related]  

  • 19. Testosterone levels in benign prostatic hypertrophy and prostate cancer.
    Mearini L; Costantini E; Zucchi A; Mearini E; Bini V; Cottini E; Porena M
    Urol Int; 2008; 80(2):134-40. PubMed ID: 18362481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigative clinical study on prostate cancer part IV: exploring functional relationships of total testosterone predicting free testosterone and total prostate-specific antigen in operated prostate cancer patients.
    Porcaro AB; Petrozziello A; Migliorini F; Lacola V; Romano M; Sava T; Ghimenton C; Caruso B; Zecchini Antoniolli S; Rubilotta E; Monaco C; Comunale L
    Urol Int; 2011; 86(4):399-406. PubMed ID: 21508618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.